Phospholipase Levels and Serological Markers of Atherosclerosis - PLASMA


Secretory phospholipase A2 is important in the development of atherosclerosis.

The goal of this dose-response trial was to evaluate the safety and efficacy of one of four doses of secretory phospholipase A2 inhibitor compared with placebo on secretory phospholipase A2 concentration.